251 related articles for article (PubMed ID: 28319198)
1. Methamphetamine induces Shati/Nat8L expression in the mouse nucleus accumbens via CREB- and dopamine D1 receptor-dependent mechanism.
Uno K; Miyazaki T; Sodeyama K; Miyamoto Y; Nitta A
PLoS One; 2017; 12(3):e0174196. PubMed ID: 28319198
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of Shati/Nat8l, an N-acetyltransferase, in the nucleus accumbens attenuates the response to methamphetamine via activation of group II mGluRs in mice.
Miyamoto Y; Ishikawa Y; Iegaki N; Sumi K; Fu K; Sato K; Furukawa-Hibi Y; Muramatsu S; Nabeshima T; Uno K; Nitta A
Int J Neuropsychopharmacol; 2014 Aug; 17(8):1283-94. PubMed ID: 24559655
[TBL] [Abstract][Full Text] [Related]
3. Inhibitory effects of Shati/Nat8l overexpression in the medial prefrontal cortex on methamphetamine-induced conditioned place preference in mice.
Haddar M; Uno K; Azuma K; Muramatsu SI; Nitta A
Addict Biol; 2020 May; 25(3):e12749. PubMed ID: 30950164
[TBL] [Abstract][Full Text] [Related]
4. Deletion of SHATI/NAT8L increases dopamine D1 receptor on the cell surface in the nucleus accumbens, accelerating methamphetamine dependence.
Toriumi K; Kondo M; Nagai T; Hashimoto R; Ohi K; Song Z; Tanaka J; Mouri A; Koseki T; Yamamori H; Furukawa-Hibi Y; Mamiya T; Fukushima T; Takeda M; Nitta A; Yamada K; Nabeshima T
Int J Neuropsychopharmacol; 2014 Mar; 17(3):443-53. PubMed ID: 24246274
[TBL] [Abstract][Full Text] [Related]
5. Regulatory system of mGluR group II in the nucleus accumbens for methamphetamine-induced dopamine increase by the medial prefrontal cortex.
Haddar M; Uno K; Hamatani K; Muramatsu SI; Nitta A
Neuropsychopharmacol Rep; 2019 Sep; 39(3):209-216. PubMed ID: 31283871
[TBL] [Abstract][Full Text] [Related]
6. Dopamine D
Tu G; Ying L; Ye L; Zhao J; Liu N; Li J; Liu Y; Zhu M; Wu Y; Xiao B; Guo H; Guo F; Wang H; Zhang L; Zhang L
Biol Psychiatry; 2019 Dec; 86(11):820-835. PubMed ID: 31060803
[TBL] [Abstract][Full Text] [Related]
7. A novel molecule "shati" is involved in methamphetamine-induced hyperlocomotion, sensitization, and conditioned place preference.
Niwa M; Nitta A; Mizoguchi H; Ito Y; Noda Y; Nagai T; Nabeshima T
J Neurosci; 2007 Jul; 27(28):7604-15. PubMed ID: 17626222
[TBL] [Abstract][Full Text] [Related]
8. Deletion of SHATI/NAT8L decreases the N-acetylaspartate content in the brain and induces behavioral deficits, which can be ameliorated by administering N-acetylaspartate.
Toriumi K; Mamiya T; Song Z; Honjo T; Watanabe H; Tanaka J; Kondo M; Mouri A; Kim HC; Nitta A; Fukushima T; Nabeshima T
Eur Neuropsychopharmacol; 2015 Nov; 25(11):2108-17. PubMed ID: 26361739
[TBL] [Abstract][Full Text] [Related]
9. Thioredoxin-1 downregulation in the nucleus accumbens promotes methamphetamine-primed reinstatement in mice.
Huang M; Yan C; Yang X; Zhou X; Lv W; Guo N; Li Y; Bai J
Neuropharmacology; 2018 Sep; 139():117-123. PubMed ID: 29981334
[TBL] [Abstract][Full Text] [Related]
10. Knockdown of dopamine D₂ receptors in the nucleus accumbens core suppresses methamphetamine-induced behaviors and signal transduction in mice.
Miyamoto Y; Iida A; Sato K; Muramatsu S; Nitta A
Int J Neuropsychopharmacol; 2014 Oct; 18(4):. PubMed ID: 25522385
[TBL] [Abstract][Full Text] [Related]
11. A Single Medical Marker for Diagnosis of Methamphetamine Addiction - DNA Methylation of SHATI/NAT8L Promoter Sites from Patient Blood.
Yuka K; Nishizawa D; Hasegawa J; Uno K; Miyanishi H; Ujike H; Ozaki N; Inada T; Iwata N; Sora I; Iyo M; Yamada M; Kondo N; Won MJ; Naruse N; Uehara-Aoyama K; Ikeda K; Nitta A
Curr Pharm Des; 2020; 26(2):260-264. PubMed ID: 31924153
[TBL] [Abstract][Full Text] [Related]
12. Induction of neuronal axon outgrowth by Shati/Nat8l by energy metabolism in mice cultured neurons.
Sumi K; Uno K; Matsumura S; Miyamoto Y; Furukawa-Hibi Y; Muramatsu S; Nabeshima T; Nitta A
Neuroreport; 2015 Sep; 26(13):740-6. PubMed ID: 26164607
[TBL] [Abstract][Full Text] [Related]
13. The role of tissue plasminogen activator in methamphetamine-related reward and sensitization.
Nagai T; Noda Y; Ishikawa K; Miyamoto Y; Yoshimura M; Ito M; Takayanagi M; Takuma K; Yamada K; Nabeshima T
J Neurochem; 2005 Feb; 92(3):660-7. PubMed ID: 15659235
[TBL] [Abstract][Full Text] [Related]
14. Possible involvement of type 1 inositol 1,4,5-trisphosphate receptors up-regulated by dopamine D1 and D2 receptors in mouse nucleus accumbens neurons in the development of methamphetamine-induced place preference.
Kurokawa K; Mizuno K; Ohkuma S
Neuroscience; 2012 Dec; 227():22-9. PubMed ID: 23000618
[TBL] [Abstract][Full Text] [Related]
15. Cocaine-Dependent Acquisition of Locomotor Sensitization and Conditioned Place Preference Requires D1 Dopaminergic Signaling through a Cyclic AMP, NCS-Rapgef2, ERK, and Egr-1/Zif268 Pathway.
Jiang SZ; Sweat S; Dahlke SP; Loane K; Drossel G; Xu W; Tejeda HA; Gerfen CR; Eiden LE
J Neurosci; 2021 Jan; 41(4):711-725. PubMed ID: 33268547
[TBL] [Abstract][Full Text] [Related]
16. Shati/Nat8l deficiency disrupts adult neurogenesis and causes attentional impairment through dopaminergic neuronal dysfunction in the dentate gyrus.
Wulaer B; Kunisawa K; Hada K; Jaya Suento W; Kubota H; Iida T; Kosuge A; Nagai T; Yamada K; Nitta A; Yamamoto Y; Saito K; Mouri A; Nabeshima T
J Neurochem; 2021 May; 157(3):642-655. PubMed ID: 32275776
[TBL] [Abstract][Full Text] [Related]
17. Methamphetamine Activates Toll-Like Receptor 4 to Induce Central Immune Signaling within the Ventral Tegmental Area and Contributes to Extracellular Dopamine Increase in the Nucleus Accumbens Shell.
Wang X; Northcutt AL; Cochran TA; Zhang X; Fabisiak TJ; Haas ME; Amat J; Li H; Rice KC; Maier SF; Bachtell RK; Hutchinson MR; Watkins LR
ACS Chem Neurosci; 2019 Aug; 10(8):3622-3634. PubMed ID: 31282647
[TBL] [Abstract][Full Text] [Related]
18. Shati/Nat8l knockout mice show behavioral deficits ameliorated by atomoxetine and methylphenidate.
Toriumi K; Tanaka J; Mamiya T; Alkam T; Kim HC; Nitta A; Nabeshima T
Behav Brain Res; 2018 Feb; 339():207-214. PubMed ID: 29203337
[TBL] [Abstract][Full Text] [Related]
19. Methamphetamine Induces Dopamine Release in the Nucleus Accumbens Through a Sigma Receptor-Mediated Pathway.
Hedges DM; Obray JD; Yorgason JT; Jang EY; Weerasekara VK; Uys JD; Bellinger FP; Steffensen SC
Neuropsychopharmacology; 2018 May; 43(6):1405-1414. PubMed ID: 29185481
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
